home All News open_in_new Full Article

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

− Study met the primary endpoint, with a significantly higher proportion of clinical responders on rusfertide compared to placebo − All four key secondary endpoints were met, including EU primary endpoint and patient-reported outcomes − Rusfertide was generally well tolerated; no new safety findings were observed in the study NEWARK, Calif. & OSAKA, Japan & […]


today 9 h. ago attach_file Science

attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Science
attach_file Politics
attach_file Culture
attach_file Culture
attach_file Events
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Other
attach_file Other
attach_file Other


ID: 1689455894
Add Watch Country

arrow_drop_down